These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 17267329)

  • 21. [Results of radioiodine therapy in 47 patients with distant metastases of differentiated thyroid carcinoma].
    Miyamoto S; Kasagi K; Endo K; Iida Y; Hidaka A; Hatabu H; Konishi J
    Nihon Igaku Hoshasen Gakkai Zasshi; 1991 Jul; 51(7):810-21. PubMed ID: 1891347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radioiodine therapy of metastatic lesions of differentiated thyroid cancer.
    Luster M; Hänscheid H; Freudenberg LS; Verburg FA
    J Endocrinol Invest; 2012; 35(6 Suppl):21-9. PubMed ID: 23014070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 131I therapy of thyroid cancer patients.
    Reiners C; Farahati J
    Q J Nucl Med; 1999 Dec; 43(4):324-35. PubMed ID: 10731783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usefulness of recombinant human TSH aided radioiodine doses administered in patients with differentiated thyroid carcinoma.
    Pitoia F; Tamer EE; Schere DB; Passerieu M; Bruno OD; Niepomniszcze H
    Medicina (B Aires); 2006; 66(2):125-30. PubMed ID: 16715760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defects in iodide metabolism in thyroid cancer and implications for the follow-up and treatment of patients.
    Schlumberger M; Lacroix L; Russo D; Filetti S; Bidart JM
    Nat Clin Pract Endocrinol Metab; 2007 Mar; 3(3):260-9. PubMed ID: 17315034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Radioiodine in the treatment of generalized papillary and follicular thyroid carcinoma].
    Mäenpää H
    Duodecim; 2014; 130(6):573-9. PubMed ID: 24724456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Experience with a high-dose therapy concept in metastatic differentiated thyroid cancer].
    Grünwald F; Ruhlmann J; Ammari B; Knopp R; Hotze A; Biersack HJ
    Nuklearmedizin; 1988 Dec; 27(6):266-71. PubMed ID: 3217257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dosimetry and thyroid cancer: the individual dosage of radioiodine.
    Lassmann M; Reiners C; Luster M
    Endocr Relat Cancer; 2010 Sep; 17(3):R161-72. PubMed ID: 20448022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant human thyroid-stimulating hormone (rhTSH) in the radioablation of well-differentiated thyroid cancer: preliminary therapeutic experience.
    Perros P
    J Endocrinol Invest; 1999; 22(11 Suppl):30-4. PubMed ID: 10727003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radioiodine post-surgical remnant ablation in patients with differentiated thyroid cancer: news from the last 10 years.
    Molinaro E; Pieruzzi L; Viola D
    J Endocrinol Invest; 2012; 35(6 Suppl):16-20. PubMed ID: 23014069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Postoperative treatment of differentiated thyroid carcinoma with radioiodine-131].
    Lin YS
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jan; 54(1):62-68. PubMed ID: 30704175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radioiodine refractory differentiated thyroid cancer.
    Jin Y; Van Nostrand D; Cheng L; Liu M; Chen L
    Crit Rev Oncol Hematol; 2018 May; 125():111-120. PubMed ID: 29650270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radioiodine therapy in differentiated thyroid carcinoma.
    Salvatori M; Rufini V; Garganese MC; Di Giuda D
    Rays; 2000; 25(2):221-38. PubMed ID: 11370540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of the plan of therapy on prognosis in thyroid cancer].
    Schümichen C; Schmitt E; Scheuffele C; Blattmann H; Pauli-Harnasch C
    Nuklearmedizin; 1983 Apr; 22(2):97-105. PubMed ID: 6866782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radioiodine treatment for malignant thyroid disease.
    Berg G
    Acta Oncol; 2006; 45(8):1041-5. PubMed ID: 17118836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. International Czech and Slovak cooperation in the treatment of patients with differentiated thyroid cancer.
    Kraft O; Reznák I
    Nucl Med Rev Cent East Eur; 2006; 9(1):84-8. PubMed ID: 16791814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radioiodine Refractory Differentiated Thyroid Cancer: Time to Update the Classifications.
    Van Nostrand D
    Thyroid; 2018 Sep; 28(9):1083-1093. PubMed ID: 30105931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Controversy over radioiodine ablation in thyroid cancer: who benefits?
    Yoo DC; Noto RB; Mazzaglia PJ
    Surg Clin North Am; 2014 Jun; 94(3):573-86. PubMed ID: 24857577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of radioactive iodine for adjuvant therapy and treatment of metastases.
    Jonklaas J
    J Natl Compr Canc Netw; 2007 Jul; 5(6):631-40. PubMed ID: 17623614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radioiodine for High Risk and Radioiodine Refractory Thyroid Cancer: Current Concepts in Management.
    Newbold KL; Flux G; Wadsley J
    Clin Oncol (R Coll Radiol); 2017 May; 29(5):307-309. PubMed ID: 28139379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.